» Articles » PMID: 17395475

Postnatal Dietary Choline Supplementation Alters Behavior in a Mouse Model of Rett Syndrome

Overview
Journal Neurobiol Dis
Specialty Neurology
Date 2007 Mar 31
PMID 17395475
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Rett syndrome (RTT), a neurodevelopmental disorder primarily affecting females, is accompanied by behavioral and neuropathological abnormalities and decreases in brain cholinergic markers. Because the cholinergic system is associated with cognitive and motor functions, cholinergic deficits in RTT may underlie some of the behavioral abnormalities. In rodents, increased choline availability during development enhances transmission at cholinergic synapses and improves behavioral performance throughout life. We examined whether choline supplementation of nursing dams would attenuate deficits in Mecp2(1lox) offspring, a mouse model of RTT. Dams were given choline in drinking water, and pups nursed from birth to weaning. Offspring were assessed on development and behavior. In Mecp2(1lox) males, choline supplementation improved motor coordination and locomotor activity, whereas in females it enhanced grip strength. Choline supplementation did not improve response to fear conditioning. Postnatal choline supplementation attenuates some behavioral deficits in Mecp2(1lox) mice and should be explored further as a therapeutic agent in RTT.

Citing Articles

The role of prenatal choline and its impact on neurodevelopmental disorders.

Mujica-Coopman M, Paules E, Trujillo-Gonzalez I Front Nutr. 2024; 11:1463983.

PMID: 39624684 PMC: 11610251. DOI: 10.3389/fnut.2024.1463983.


Diet and Nutrients in Rare Neurological Disorders: Biological, Biochemical, and Pathophysiological Evidence.

Briglia M, Allia F, Avola R, Signorini C, Cardile V, Romano G Nutrients. 2024; 16(18).

PMID: 39339713 PMC: 11435074. DOI: 10.3390/nu16183114.


Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.

Gautier M, Kelley C, Lee S, Alldred M, McDaid J, Mufson E Neurobiol Dis. 2023; 188:106332.

PMID: 37890559 PMC: 10752300. DOI: 10.1016/j.nbd.2023.106332.


The impact of early-life environment on absence epilepsy and neuropsychiatric comorbidities.

Sarkisova K, van Luijtelaar G IBRO Neurosci Rep. 2022; 13:436-468.

PMID: 36386598 PMC: 9649966. DOI: 10.1016/j.ibneur.2022.10.012.


Optimized Administration of the M PAM VU0467154 Demonstrates Broad Efficacy, but Limited Effective Concentrations in Mice.

Cikowski J, Holt C, Arthur B, Smith M, Gonzalez S, Lindsley C ACS Chem Neurosci. 2022; 13(13):1891-1901.

PMID: 35671352 PMC: 9266622. DOI: 10.1021/acschemneuro.2c00113.